Workflow
智能互动产品
icon
Search documents
医疗保健成热门投资标的,港股Home Control的新董事具強大背景
Sou Hu Wang· 2025-09-28 11:30
Group 1 - The healthcare sector has become a hot investment target since 2025, with a remarkable increase of 91.2% from the beginning of the year to late August, making it the best-performing sector among the 12 industry indices of the Hang Seng Composite Index [1] - Home Control, a Hong Kong stock, is expanding into the healthcare field from its core IoT business, establishing connections with Singaporean medical enterprises and Indonesian consortiums [1] - The management team of Home Control includes experienced professionals from Philips, indicating a strong international board background that enhances the company's strategic positioning in the healthcare sector [1] Group 2 - Newly appointed non-executive director Ma Ying has extensive experience in digital healthcare and has established significant connections in the public welfare and education sectors, which may benefit the company's future strategic expansion in fintech and healthcare integration [1] - Another new independent non-executive director, Chen Yizhong, is the COO of OUE Limited, a Singapore-listed healthcare and real estate group, which has substantial financial resources and networks due to its ties with the Indonesian conglomerate Lippo Group [2] - OUE Limited operates over 130 clinics and medical centers across Singapore, China, Myanmar, Indonesia, and Japan, and collaborates with Chinese University of Hong Kong to establish an international medical center in Shenzhen [2] Group 3 - Home Control has launched a strategic initiative in the healthcare sector by establishing a wholly-owned subsidiary, Orbiva Limited, in Hong Kong, focusing on AIoT-enabled home healthcare platforms and ecosystems [3] - The company plans to develop smart health monitoring devices and interactive products, integrating innovative technologies such as artificial intelligence and Web3 to enhance platform capabilities and expand application scenarios [3] - The healthcare segment contributed nearly 20% to the company's growth in the first half of 2025, indicating significant potential for attracting investment as it integrates innovative technologies into a one-stop health management platform [3]